The Benefits of Phytotherapy in Chronic Pelvic Pain Syndrome
In: Romanian Journal of Military Medicine, Band 127, Heft 4, S. 263-269
ISSN: 2501-2312
Chronic pelvic pain syndrome (CPPS) presents a diagnostic challenge due to its multifactorial nature, often involving
urological, gynecological, and psychological components. This study focuses on the effectiveness of prophylactic phytotherapy in
preventing CPPS recurrence, aiming to mitigate symptoms and psychosocial impact. The study includes 74 patients following a
six-month treatment regimen with Graminex, Seronoa Repens, Curcuma Longa, and Acediboswellic ke-to-acetyl-11. Symptom
assessment employs the IPSS and NIH-CPSI questionnaires, conducted at 3, 6, 8, 9, and 12 months. Patients exhibit significant
improvements in IPSS scores, with maintenance of treatment impact observed at 3, 6, and 9 months. Interruption of therapy
leads to symptom recurrence, but upon resumption, responses are more effective. The third group, under observation for three
months, reports positive outcomes. Both IPSS and NIH-CPSI scores show a consistent impact on urinary symptoms and pelvic pain,
indicating the therapy's effectiveness. The study demonstrates a concordance in the positive effects of phytotherapy across
different age groups, emphasizing its efficacy in alleviating urinary symptoms and pelvic pain in CPPS patients. Symptom
remission or improvement in quality of life is reported, with a notable tropism for symptom reduction in the cold season. Patient
adherence to treatment is high, and even after treatment interruption, resumed therapy yields significant improvements. The
observed benefits include the absence of pelvic pain, dysuria, and enhanced sexual competence, contributing to an overall
improvement in the quality of life for patients with CPPS.